Holley Performance Brands Scheduled to Announce Q3 2025 Results on November 7, 2025
Third Quarter Financial Results Announcement: Holley Performance Brands will release its third quarter 2025 financial results on November 7, 2025, with a conference call scheduled for 8:30 am Eastern Time.
Conference Call Details: The call will be hosted by CEO Matthew Stevenson and CFO Jesse Weaver, and will be accessible via dial-in and webcast, with a replay available until November 14, 2025.
Company Overview: Holley Performance Brands specializes in high-performance automotive products and manages a portfolio of well-known brands, focusing on various consumer segments within the automotive aftermarket industry.
Commitment to Innovation: The company emphasizes its dedication to enhancing the automotive enthusiast experience through innovative products and strategic acquisitions.
Trade with 70% Backtested Accuracy
Analyst Views on HLLY
About HLLY
About the author

Cytokinetics Faces Shareholder Claims Over Executive Misconduct, Potential for Corporate Reforms
- Shareholder Claims Investigation: Grabar Law Office is investigating whether Cytokinetics' executives breached their fiduciary duties, allowing shareholders who purchased shares before December 27, 2023, to seek corporate reforms and fund recovery.
- FDA Review Delays: Cytokinetics acknowledged in May 2025 that it failed to include a Risk Evaluation and Mitigation Strategy in its New Drug Application, resulting in the FDA extending the review date from September 2025 to December 2025, which negatively impacted the company's reputation and shareholder confidence.
- False Statement Allegations: A federal securities fraud class action alleges that Cytokinetics' executives made misleading statements that caused significant harm to shareholders, potentially affecting the company's future financing capabilities.
- Legal Consequences: Shareholders who purchased shares before December 27, 2023, can seek court-approved incentive awards, highlighting potential flaws in corporate governance and legal risks.

Holley Inc. Faces Shareholder Lawsuit Over Securities Fraud Allegations
- Shareholder Lawsuit Initiated: Current shareholders of Holley Inc. (NYSE: HLLY) can seek corporate reforms and fund returns, indicating significant legal challenges that may impact shareholder confidence and market performance.
- Fraud Allegations Survive: A federal securities fraud class action has survived a motion to dismiss, alleging that Holley executives failed to disclose deteriorating relationships with distributors, which could lead to declining sales and affect future revenues.
- Market Trust Crisis: Holley's excessive focus on its direct-to-consumer channel has damaged relationships with distributors, which are crucial for revenue, potentially resulting in market share loss and diminished competitive standing.
- Consequences of Integration Failure: Holley has failed to effectively integrate its acquisitions, leading to operational inefficiencies and inventory management issues, which exacerbate financial pressures and could hinder the company's long-term strategic growth.





